Zobrazeno 1 - 10
of 252
pro vyhledávání: '"Momen M. Wahidi"'
Autor:
Robert J. Lentz, MD, Katherine Frederick-Dyer, MD, Virginia B. Planz, MD, Tatsuki Koyama, PhD, Matthew C. Aboudara, MD, Briana Swanner, BS, Lance Roller, MS, See-Wei Low, MD, Cristina Salmon, MD, Sameer K. Avasarala, MD, Todd C. Hoopman, MD, Momen M. Wahidi, MD, Kamran Mahmood, MD, MPH, George Z. Cheng, MD, PhD, James M. Katsis, MD, Jonathan S. Kurman, MD, Pierre-François D’Haese, PhD, Joyce Johnson, MD, Eric L. Grogan, MD, MPH, Charla Walston, AGACNP-BC, Lonny Yarmus, DO, Gerard A. Silvestri, MD, Otis B. Rickman, DO, Najib M. Rahman, DPhil, Fabien Maldonado, MD
Publikováno v:
CHEST Pulmonary, Vol 2, Iss 3, Pp 100050- (2024)
Background: Lung nodule incidence is increasing. Many nodules require biopsy to discriminate between benign and malignant causes. The gold standard for minimally invasive biopsy, CT scan-guided transthoracic needle biopsy (CT-TTNB), has not been comp
Externí odkaz:
https://doaj.org/article/898186340bd7445888d47d6e9038e66b
Autor:
Peter Mazzone, Travis Dotson, Momen M. Wahidi, Michael Bernstein, Hans J. Lee, David Feller Kopman, Lonny Yarmus, Duncan Whitney, Christopher Stevenson, Jianghan Qu, Marla Johnson, P. Sean Walsh, Jing Huang, Lori R. Lofaro, Sangeeta M. Bhorade, Giulia C. Kennedy, Avrum Spira, M. Patricia Rivera, The AEGIS Study Team, The Percepta Registry Investigators
Publikováno v:
PLoS ONE, Vol 17, Iss 7 (2022)
The Percepta Genomic Sequencing Classifier (GSC) was developed to up-classify as well as down-classify the risk of malignancy for lung lesions when bronchoscopy is non-diagnostic. We evaluated the performance of Percepta GSC in risk re-classification
Externí odkaz:
https://doaj.org/article/7975638e3f9c43ddaa1950ed80c7fd65
Autor:
Coral X. Giovacchini, Edward R. Kessler, Christopher M. Merrick, Junheng Gao, Xiaofei Wang, Momen M. Wahidi, Scott L. Shofer, George Z. Cheng, Kamran Mahmood
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Malignant central airway obstruction (CAO) occurs in approximately 20–30% of patients with lung cancer and is associated with debilitating symptoms and poor prognosis. Multimodality therapeutic bronchoscopy can relieve malignant
Externí odkaz:
https://doaj.org/article/664c09530c23488c8a7aead8e6387375
Autor:
Sandeep J. Khandhar, Mark R. Bowling, Javier Flandes, Thomas R. Gildea, Kristin L. Hood, William S. Krimsky, Douglas J. Minnich, Septimiu D. Murgu, Michael Pritchett, Eric M. Toloza, Momen M. Wahidi, Jennifer J. Wolvers, Erik E. Folch, for the NAVIGATE Study Investigators
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Electromagnetic navigation bronchoscopy (ENB) is an image-guided, minimally invasive approach that uses a flexible catheter to access pulmonary lesions. Methods NAVIGATE is a prospective, multicenter study of the superDimension™
Externí odkaz:
https://doaj.org/article/190dc90b88114d41bf95b4692d7a592d
Autor:
Momen M. Wahidi, Hubert B. Haywood, Geoffrey D. Bass, Ian Nathanson, Anand Chowdhury, Devdutta Sangvai
Publikováno v:
Chest. 163:1193-1200
Publikováno v:
Respiration. :1-7
Background: Peripheral bronchoscopy is often performed to biopsy peripheral pulmonary lesions. Despite technological advancements to improve reach and access to the lung periphery, the diagnostic yield of peripheral bronchoscopy has been inconsistent
Autor:
Momen M. Wahidi, Carla R. Lamb, Kevin Kovitz, Colleen Keyes, Rabih Bechara, Coral X. Giovacchini, Kim French, Samira Shojaee, Ali Musani, George Eapen, David E. Ost
Publikováno v:
Journal of Bronchology & Interventional Pulmonology. 30:129-134
Autor:
Maulin Patel, Junad Chowdhury, Huaqing Zhao, Xiaoning Lu, Stephanie Roth, Coral X. Giovacchini, Momen M. Wahidi, Gerard Criner
Publikováno v:
Journal of Bronchology & Interventional Pulmonology. 29:224-237
Pharmacologic therapeutics for advanced emphysema have limited benefit. Bronchoscopic lung volume reduction with endobronchial valves (EBVs) have reported improvements in lung function, breathlessness, and quality of life through randomized clinical
Autor:
Jennifer Toth, Joel N. Kline, Geoffrey Chupp, Jennifer Trevor, Gerard A. Silvestri, Michel Laviolette, Sundeep Bansal, Richard Tejedor, Nick Kahlstrom, Mark T. Dransfield, Andrew R. Haas, Charlene McEvoy, G. Mark Grubb, Jamie Hey, J. Scott Ferguson, Michael Simoff, Carla Lamb, Edmund McMullen, Momen M. Wahidi, Kyle B. Enfield, Sumita Khatri, Peter LaCamera, J. Mark FitzGerald, Adrian Shifren, Jennifer L. Olson, D. Kyle Hogarth, Mario Castro, Adnan Majid, Marc McClelland
Publikováno v:
Chest. 161:614-628
Background Bronchial thermoplasty is a device-based treatment for subjects ≥18 years with severe asthma poorly controlled with inhaled corticosteroids and long-acting beta-agonists. The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermopl
Autor:
Jiayuan Sun, Gerard J. Criner, David Dibardino, Shiyue Li, Daniel Nader, Bing Lam, Lisa Kopas, Momen M. Wahidi, Adnan Majid, Robert Marron, Steven Verga, Felix J. F. Herth
Publikováno v:
Respirology. 27:357-365
Virtual bronchoscopic navigation (VBN) with fused fluoroscopy and vessel mapping provides a point of entry (POE) for puncturing airway wall to biopsy lesions. The study was designed to evaluate the safety and efficacy of this technology to diagnose p